Cargando…

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer

Detalles Bibliográficos
Autor principal: Alliot, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747700/
https://www.ncbi.nlm.nih.gov/pubmed/15305190
http://dx.doi.org/10.1038/sj.bjc.6602100
_version_ 1782172118004269056
author Alliot, C
author_facet Alliot, C
author_sort Alliot, C
collection PubMed
description
format Text
id pubmed-2747700
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27477002009-09-21 Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer Alliot, C Br J Cancer Letter to the Editor Nature Publishing Group 2004-09-13 2004-08-10 /pmc/articles/PMC2747700/ /pubmed/15305190 http://dx.doi.org/10.1038/sj.bjc.6602100 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Alliot, C
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
title Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
title_full Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
title_fullStr Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
title_full_unstemmed Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
title_short Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
title_sort adjuvant immunochemotherapy with oral tegafur/uracil plus psk in patients with stage ii or iii colorectal cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747700/
https://www.ncbi.nlm.nih.gov/pubmed/15305190
http://dx.doi.org/10.1038/sj.bjc.6602100
work_keys_str_mv AT alliotc adjuvantimmunochemotherapywithoraltegafururacilpluspskinpatientswithstageiioriiicolorectalcancer